Thursday, November 03, 2011

Discovery Helps Explain Progression of Lou Gehrig's Disease, Offers New Therapy Approach


ScienceDaily (Oct. 17, 2011)Researchers in Uruguay and Oregon have discovered a previously unknown type of neural cell that appears to be closely linked to the progression of amytrophic lateral sclerosis, or Lou Gehrig's disease, that they believe will provide an important new approach to therapies.

There is now no treatment for this disease, which causes progressive death of motor neurons, serious debility, paralysis and ultimately death within a few years.

Even a way to slow its progression would be hugely important, scientists say.

The findings were reported October 17 in Proceedings of the National Academy of Sciences, by researchers from the Pasteur Institute of Montevideo, Clemente Estable Institute and the Linus Pauling Institute at Oregon State University.

The scientists discovered a type of "astrocyte" cell that displays atypical behavior and causes motor neuron death. They are referring to them as aberrant astrocyte, or AbA cells. Astrocyte cells are very common in the brain, and usually help provide metabolic support and protection to neurons. But they can sometimes also become toxic and cause the death of neuron cells.

The researchers now have markers to identify the AbA cell, and found them adjacent to dying motor neuron cells in the spinal cord of laboratory animals with ALS.

The newly-identified AbA cells are selectively toxic to motor neurons, the researchers reported in the study, and 10 times more toxic than any other astrocyte cell known to exist. That level of toxicity is unprecedented, they said.

"We believe these aberrant astrocyte cells are helping drive the progression of ALS," said Joe Beckman, an OSU professor of biochemistry and principal investigator in the Linus Pauling Institute who has been working on amyotrophic lateral sclerosis for more than 15 years.

To read more about ALS, please click on the above title.

No comments: